| abstract |
The present invention is related to compounds, compositions and methods of treating viral infections. Compounds of the present invention have the following general formula: wherein R is selected from -CH2OH, -CO2R2, -CONR3R4, or COR5, wherein R2 is hydrogen or a lower alkyl group, R3 and R4 are each independently hydrogen or a lower alkyl group, R5 is an amino acid residue bound via a terminal nitrogen or peptide having at least two amino acid residues; and wherein R1 is C5-C13 alkyl, aryl, aralkyl, aralkyl(lower alkyl)ether, or C5-C13 alkyl(lower alkyl)ether. |